Ikarian Capital’s MacroGenics MGNX Stock Holding History

Ikarian Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$346K	Hold	74,893	–	–	0.04%	133
2026 Q1	$216K	Hold	74,893	–	–	0.02%	139
2025 Q4	$121K	Sell	74,893 -5,178	-6%	-$8.14K	0.01%	160
2025 Q3	$135K	Hold	80,071	–	–	0.01%	160
2025 Q2	$96.9K	Hold	80,071	–	–	0.02%	122
2025 Q1	$102K	Hold	80,071	–	–	0.01%	152
2024 Q4	$260K	Sell	80,071 -8	-0%	-$29	0.04%	146
2024 Q3	$263K	Sell	80,079 -120,000	-60%	-$467K	0.04%	134
2024 Q2	$850K	Sell	200,079 -118,088	-37%	-$1.15M	0.15%	79
2024 Q1	$4.68M	Buy	+318,167	New	+$4.81M	0.51%	57
2023 Q2	–	Sell	-250,000	Closed	-$1.79M	–	151
2023 Q1	$1.79M	Buy	+250,000	New	+$1.51M	0.41%	61
2022 Q2	–	Sell	-164,119	Closed	-$1.45M	–	176
2022 Q1	$1.45M	Buy	164,119 +8,072	+5%	+$89.1K	0.19%	84
2021 Q4	$2.51M	Sell	156,047 -32,431	-17%	-$610K	0.37%	56
2021 Q3	$3.95M	Sell	188,478 -271,124	-59%	-$6.53M	0.28%	81
2021 Q2	$12.3M	Sell	459,602 -40,867	-8%	-$1.2M	1%	25
2021 Q1	$15.9M	Buy	+500,469	New	+$12.2M	0.54%	43
2020 Q2	–	Sell	-360,030	Closed	-$2.1M	–	195
2020 Q1	$2.1M	Buy	360,030 +350,000	+3,490%	+$3.18M	0.16%	95
2019 Q4	$109K	Buy	+10,030	New	+$99.3K	0.02%	105

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Ikarian Capital's MGNX Position: Q2 2026 in Review

Ikarian Capital held its MacroGenics (MGNX) position steady in Q2 2026 at 74,893 shares worth $346K. The position accounts for 0.04% of the portfolio, ranked #133.

Ikarian Capital first reported a position in MGNX in Q4 2019 and has held it in 18 quarters since. The position peaked at $15.9M in Q1 2021. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Ikarian Capital held 74,893 shares of MacroGenics worth $346K as of Q2 2026.
Ikarian Capital left its MacroGenics share count unchanged in Q2 2026.
MacroGenics made up 0.04% of Ikarian Capital's portfolio in Q2 2026, its #133 holding.
Ikarian Capital first reported a position in MacroGenics in Q4 2019 and has held it in 18 quarters since.
Ikarian Capital's MacroGenics position peaked at $15.9M in Q1 2021.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.